We've noticed that you're using an ad blocker

Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.

It's off now Dismiss How do I disable my ad blocker?
❌

How to disable your ad blocker for our site:

Adblock / Adblock Plus
  • Click on the AdBlock / AdBlock Plus icon on the top right of your browser.
  • Click “Don’t run on pages on this domain.” OR “Enabled on this site.”
  • Close this help box and click "It's off now".
Firefox Tracking Prevention
  • If you are Private Browsing in Firefox, "Tracking Protection" may casue the adblock notice to show. It can be temporarily disabled by clicking the "shield" icon in the address bar.
  • Close this help box and click "It's off now".
Ghostery
  • Click the Ghostery icon on your browser.
  • In Ghostery versions < 6.0 click “Whitelist site.” in version 6.0 click “Trust site.”
  • Close this help box and click "It's off now".
uBlock / uBlock Origin
  • Click the uBlock / uBlock Origin icon on your browser.
  • Click the “power” button in the menu that appears to whitelist the current website
  • Close this help box and click "It's off now".
  • ONCOLOGY
  • News
  • Blogs
  • Topics
  • Hematology
  • Image IQ
  • Podcasts
  • Videos
  • Slideshows
  • Conferences

Modern Medicine Network
  • Login
  • Register
Skip to main content
Modern Medicine Network
  • Login
  • Register
Menu
User
Home
  • ONCOLOGY
  • News
  • Blogs
  • Topics
  • Hematology
  • Image IQ
  • Podcasts
  • Videos
  • Slideshows
  • Conferences

SUBSCRIBE: Print / eNewsletter

Study Finds Clue to Sunburn-Melanoma Link

Jun 1, 1999
Volume: 
8
Issue: 
6
  • Skin Cancer (Nonmelanoma), Melanoma, Melanoma

NEW YORK—The association between intermittent but intense sun
exposure and malignant melanoma
has long been recognized, though the reasons behind it have not been
understood. Researchers have now uncovered mechanisms likely to
explain why this specific pattern of sun exposure leads to the
deadliest form of skin cancer.

Barbara Gilchrest, MD, professor of dermatology, Boston University,
and author of “Mechanisms of Disease,” a review published
in the New England Journal of Medicine (April 29, 1999),
summarized her findings at an American Academy of Dermatology briefing.

Melanoma typically occurs in areas of the body intermittently exposed
to the sun, the middle of the back being the most common site. This
is in contrast to squamous cell and basal cell carcinomas, the two
most common skin cancers, which tend to occur in regularly
sun-exposed areas such as the face, back of the hands, and forearms,
and in people with a history of cumulative exposure
over the course of many years.

Specific DNA mutations due to ultraviolet damage are involved in all
skin cancers, she said, but the difference lies in the mechanism by
which the body repairs or counteracts that DNA damage.

Squamous and basal cell carcinomas arise in the keratinocytes,
whereas melanoma is a cancer of the melanocytes. When exposed to UV
radiation, the most severely damaged keratinocytes undergo apoptosis,
while those less severely damaged remain and continue to be
vulnerable to mutation with each subsequent exposure. Melanocytes, on
the other hand, are highly resistant to apoptosis, possibly because
they exist in far fewer numbers than keratinocytes and serve the
important and irreplaceable function of producing the protective
pigment melanin. “This resistance to cell death enables
UV-damaged melanocytes to mutate and divide,” Dr. Gilchrest said.

Furthermore, later DNA damage in human skin cells may be repaired to
an enhanced degree through a process known as the SOS response. The
production of specialized repair proteins is increased within 2 to 3
days of an initial damaging sun exposure, and parallels increased
production of melanin pigment, resulting in a tan.

The repair process is not perfect, however, and cells with DNA
defects continue to accumulate, accounting for the pattern of
cumulative damage associated with the nonmelanoma skin cancers.

A large dose of UV, such as results in a severe sunburn rather than
gradual tanning, damages keratinocytes and melanocytes alike. The
difference is that the highly damaged keratinocytes undergo
apoptosis, whereas the melanocytes remain in their damaged state.

According to Dr. Gilchrest’s hypothesis, “intermittent
high-dose exposures are expected to give rise to more melanomas than
frequent low-dose exposures because the UV injury occurs when the
melanocytes’ DNA-repair capacity is relatively low, the DNA
damage is poorly repaired, and all the damaged cells are retained.”

The incidence of malignant melanoma has risen 1,900% since 1930, a
trend Dr. Gilchrest attributes to the increase in recreational
exposure to skin areas left covered in the past. Excessive sun
exposure and severe sunburns in the first 10 to 15 years of life can
result in a threefold increase in the lifetime risk of developing
melanoma, she said.

The Academy urges sun avoidance, the use of protective clothing and a
sunscreen with an SPF of at least 15 when the sun cannot be avoided,
regular examination of all areas of the skin, and an annual skin
examination by a professional.

Related Articles

  • Secondary Prevention Strategies for Nonmelanoma Skin Cancer
  • Incidence of Merkel Cell Carcinoma Rising Sharply
  • No Clear Effect on Melanoma Outcomes With Behavioral Interventions
  • Immunotherapy Safely Treats Advanced Squamous Cell Carcinoma
  • Avelumab Approved for Treating Metastatic Merkel Cell Carcinoma

Resource Topics rightRail

  • Resource Topics
  • Partner Content
Breast Cancer
Lung Cancer
Prostate Cancer
Colorectal Cancer
Melanoma
Cutaneous T-Cell Lymphomas: Mycosis Fungoides and Sézary Syndrome
3 Keys to Success in the Oncology Care Model

Current Issue

Oncology Vol 32 No 4
Apr 15, 2018 Vol 32 No 4
Digital Edition
Subscribe
Connect with Us
  • Twitter
  • Facebook
  • LinkedIn
  • RSS
Modern Medicine Network
  • Home
  • About Us
  • Advertise
  • Advertiser Terms
  • Privacy statement
  • Terms & Conditions
  • Editorial & Advertising Policy
  • Editorial Board
  • Contact Us
Modern Medicine Network
© UBM 2018, All rights reserved.
Reproduction in whole or in part is prohibited.